MedTrace Logo

Determining the Worldwide Epidemiology of Surgical Site Infections After Gastrointestinal Surgery

NCT02662231 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12539

Last updated 2024-05-22

No results posted yet for this study

Summary

Surgical site infection (SSI) is the most common complication following major gastrointestinal surgery, affecting between 25-40% of patients. The rate of SSI doubles from low-income to high-income settings, persisting after risk adjustment. Investigating the diagnosis and treatment of SSIs remains a largely unaddressed global health priority. The impact of antibiotic resistant organisms and the effectiveness of antibiotic prophylaxis are unknown. This study aims to determine SSI rates following gastrointestinal surgery across worldwide hospital settings.

Conditions

  • Surgical Wound Infection

Interventions

PROCEDURE

Emergency, or elective gastrointestinal resection

Gastrointestinal resection is defined as complete transection and removal of a segment of the oesophagus, stomach, small bowel, colon or rectum, including cholecystectomy, and appendicectomy.

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Aneel Bhangu · University of Birmingham

  • Ewen M Harrison · University of Edinburgh

  • Edward Fitzgerald · Royal Free London NHS Foundation Trust

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-07-31
Completion
2016-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02662231 on ClinicalTrials.gov